IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$472.35 USD
+3.17 (0.68%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $470.94 -1.41 (-0.30%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | 2.69 |
EPS Last Quarter | 2.44 |
Last EPS Surprise | -14.98% |
ABR | 1.71 |
Earnings ESP
|
-0.22% |
---|---|
Current Year | 10.45 |
Next Year | 12.28 |
EPS (TTM) | 10.10 |
P/E (F1) | 45.21 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 979.32M | 966.90M | 3.91B | 4.27B |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 983.50M | 972.50M | 3.92B | 4.32B |
Low Estimate | 974.24M | 963.71M | 3.91B | 4.21B |
Year ago Sales | 915.53M | 901.60M | 3.66B | 3.91B |
Year over Year Growth Est. | 6.97% | 7.24% | 6.91% | 9.18% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.69 | 2.51 | 10.45 | 12.28 |
# of Estimates | 6 | 5 | 6 | 6 |
Most Recent Consensus | 2.70 | 2.50 | 10.45 | 12.47 |
High Estimate | 2.71 | 2.54 | 10.49 | 12.47 |
Low Estimate | 2.67 | 2.50 | 10.42 | 12.01 |
Year ago EPS | 2.53 | 2.32 | 10.06 | 10.45 |
Year over Year Growth Est. | 6.32% | 8.19% | 3.88% | 17.53% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 2 | 2 | 2 |
Down Last 60 Days | 5 | 4 | 6 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.69 | 2.51 | 10.45 | 12.28 |
7 Days Ago | 2.69 | 2.51 | 10.45 | 12.28 |
30 Days Ago | 2.71 | 2.54 | 10.57 | 12.42 |
60 Days Ago | 2.80 | 2.56 | 11.03 | 12.57 |
90 Days Ago | 2.80 | 2.56 | 11.03 | 12.57 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.69 | 2.52 | 10.45 | 12.25 |
Zacks Consensus Estimate | 2.69 | 2.51 | 10.45 | 12.28 |
Earnings ESP | -0.22% | 0.32% | 0.00% | -0.22% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.44 | 2.81 | 2.32 | 2.53 | NA |
Estimate | 2.87 | 2.68 | 2.12 | 2.37 | NA |
Difference | -0.43 | 0.13 | 0.20 | 0.16 | 0.02 |
Surprise | -14.98% | 4.85% | 9.43% | 6.75% | 1.51% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more